• Accueil >
  • Publications >
  • Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status

Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status

1 juin 2016Targeted Oncology

DOI : 10.1007/s11523-015-0403-8

Auteurs

Florence Huguet, Marie Fernet, Nicole Giocanti, Vincent Favaudon, Annette K. Larsen